Skip to Content

Paion Ag PAIOF

Morningstar Rating
$0.05 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PAIOF is trading at a 821% premium.
Price
$0.05
Fair Value
$8.81
Uncertainty
Extreme
1-Star Price
$6.46
5-Star Price
$2.86
Economic Moat
Tlyl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PAIOF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.05
Day Range
$0.050.05
52-Week Range
$0.026.30
Bid/Ask
$0.00 / $1.00
Market Cap
$376,318.95
Volume/Avg
3,055 / 14,083

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.02
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
64

Comparables

Valuation

Metric
PAIOF
ILM1
HRPK
Price/Earnings (Normalized)
15.8519.06
Price/Book Value
0.811.07
Price/Sales
0.020.213.48
Price/Cash Flow
10.524.54
Price/Earnings
PAIOF
ILM1
HRPK

Financial Strength

Metric
PAIOF
ILM1
HRPK
Quick Ratio
0.512.061.77
Current Ratio
0.762.662.07
Interest Coverage
−5.0211.223.29
Quick Ratio
PAIOF
ILM1
HRPK

Profitability

Metric
PAIOF
ILM1
HRPK
Return on Assets (Normalized)
−51.27%2.71%1.93%
Return on Equity (Normalized)
−291.82%3.62%4.84%
Return on Invested Capital (Normalized)
−63.45%3.68%3.07%
Return on Assets
PAIOF
ILM1
HRPK
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
FngdjbcrkPrtdtsl$80.3 Bil
Zoetis Inc Class A
ZTS
PydwxfcqtLsfzt$77.8 Bil
Haleon PLC ADR
HLN
GbdqdqcfBrz$37.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
TndbfzmThqyp$12.1 Bil
Viatris Inc
VTRS
NykmmqmlJcfsx$12.1 Bil
Catalent Inc
CTLT
RwxsfkpvYpysjy$10.0 Bil
Perrigo Co PLC
PRGO
SrlnrttpYntst$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
McfrlwhrpFvtgj$3.2 Bil
Curaleaf Holdings Inc
CURLF
YhwvlhqmdVdhq$3.0 Bil
Green Thumb Industries Inc
GTBIF
PflpmpscHrpsc$2.7 Bil

Sponsor Center